Affiliation:
1. Department of Clinical Pharmacy , Faculty of Pharmacy, University of Airlangga , Surabaya , Indonesia
Abstract
Abstract
Objectives
Tobacco smoking remains the primary cause of preventable mortality and morbidity in the world. The complexity of the nicotine dependency process included the withdrawal effect that triggers recurrence being the main problem. Quercetin, known as an antioxidant, binds free radicals and modulates endogenous antioxidants through Nrf2 activations is expected as a potential agent to reduce the risk of nicotine dependence. This research aims to evaluate quercetin’s effects on reducing the risk of nicotine addiction.
Methods
Conditioned Place Preference (CPP) with a biased design was used to evaluate nicotine’s reward effects in male Balb/C mice. Preconditioning test was performed on day 1; conditioning test was done twice daily on day 2–4 by administering quercetin (i.p.) 50 mg/kg along with nicotine (s.c.) 0.5 mg/kg or Cigarette Smoke Extract (CSE) (s.c.) contained nicotine 0.5 mg/kg; and postconditioning test was performed on day 5 continue with extinction test on day 6, 8, 10, 12, and reinstatement test on day 13. The duration spent in each compartment was recorded and analyzed.
Results
Nicotine 0.5 mg/kg and CSE 0.5 mg/kg significantly induced reward effects (p<0.05). There was no decrease of reward effect during the extinction-reinstatement stage of the postconditioning phase (p>0.05), while quercetin 50 mg/kg both induced along with nicotine or CSE was able to inhibit the reward effect of nicotine (p>0.05).
Conclusions
Quercetin reduced the risk of nicotine dependence and has a potential effect to use as a therapy for nicotine dependence, especially as a preventive agent.
Subject
Drug Discovery,Pharmacology,General Medicine,Physiology
Reference43 articles.
1. Thun, MJ, Carter, BD, Feskanich, D, Freedman, ND, Prentice, R, Lopez, AD. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013;368:351–64. https://doi.org/10.1056/nejmsa1211127.
2. GBD 2015 Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the global burden of disease study 2015. Lancet 2017;389:1885–906.
3. Lian, TY, Dorotheo, U. The tobacco control atlas ASEAN region, 2nd ed. Bangkok: South Asia Tobacco Control Alliace; 2018:20 p.
4. Kemenkes, RI. Hasil utama Riskesdas 2018. Jakarta: Balitbangkes; 2018:125 p.
5. Preedy, VR. Neuroscience of nicotine: mechanisms and treatment. United Kingdom: Academic Press; 2019:166 p.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献